BetaThis is a new service - your feedback will help us to improve it.
Information
Changes to when we publish influenza and RSV data
We are changing how often we publish our influenza and RSV data. From 29 May, we will update metrics for both influenza and RSV every 2 weeks instead of weekly. We will resume weekly updates in October this year.
Entry title:
Antimicrobial resistance in Klebsiella pneumoniae (K. pneumoniae)
Last updated on Thursday, 29 May 2025 at 04:00pm
This page provides information on resistance to antimicrobials in Klebsiella pneumoniae bacteraemia (bacteria found in blood specimens). Data breakdowns are available for England, by UKHSA Region and by Integrated Care Board.
Antibiotics are grouped based on the UK-AWaRe classification. These are:
Access Access antibiotics are with a narrow spectrum of activity, fewer side effects, lower costs, and importantly lower resistance potential. These are first or second choice antibiotics recommended for empiric treatment of the most common infections and should be widely available. That is to say, these antibiotics should offer the best therapeutic value while minimizing the potential for resistance.
Watch Watch antibiotics have a higher resistance potential and are broader-spectrum antibiotics. These are first or second choice antibiotics indicated for a limited number of infective syndromes. As these antibiotics are considered to have a higher potential for selection of AMR, their use should be carefully monitored.
Reserve Reserve antibiotics are “last resort” antibiotics, including new antibiotics. These are used for highly selected patients (life-threatening infections due to multi-drug-resistant bacteria) and are closely monitored and prioritized as targets of stewardship programmes to ensure continued effectiveness.
Resistance
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav, ciprofloxacin, gentamicin, piperacillin with tazobactam, amikacin, carbapenems or third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav, ciprofloxacin, gentamicin, piperacillin with tazobactam, amikacin, carbapenems or third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Amikacin (Watch)
Carbapenems (Reserve)
1 Feb 2025
3.12
1.32
1 Jan 2025
2.89
1.26
1 Dec 2024
3.13
1.66
1 Nov 2024
2.88
1.91
1 Oct 2024
2.72
1.85
1 Sep 2024
2.6
1.7
1 Aug 2024
2.64
1.47
1 Jul 2024
2.94
1.7
1 Jun 2024
2.89
1.39
1 May 2024
2.53
1.38
1 Apr 2024
2.55
1.49
1 Mar 2024
2.15
1.7
1 Feb 2024
2.53
1.7
1 Jan 2024
1.71
1.38
1 Dec 2023
1.9
1.48
1 Nov 2023
1.8
1.58
1 Oct 2023
1.97
1.77
1 Sep 2023
1.88
1.66
1 Aug 2023
2.17
1.48
1 Jul 2023
2.22
1.22
1 Jun 2023
2.59
1.36
1 May 2023
2.48
1.49
1 Apr 2023
2.26
1.64
1 Mar 2023
2.25
1.68
1 Feb 2023
1.77
1.67
1 Jan 2023
2.37
1.59
1 Dec 2022
2.61
1.52
1 Nov 2022
3.2
1.89
1 Oct 2022
3.07
1.76
1 Sep 2022
2.95
1.81
1 Aug 2022
2.14
1.62
1 Jul 2022
1.66
1.73
1 Jun 2022
1.96
1.66
1 May 2022
2.42
1.27
1 Apr 2022
3.3
1.01
1 Mar 2022
3.36
1.01
1 Feb 2022
2.96
1.14
1 Jan 2022
2.9
1.72
1 Dec 2021
2.43
1.66
1 Nov 2021
2.62
1.48
1 Oct 2021
2.17
0.99
1 Sep 2021
2.13
0.76
1 Aug 2021
1.69
0.74
1 Jul 2021
1.55
0.75
1 Jun 2021
1.22
0.8
1 May 2021
1.53
0.97
1 Apr 2021
1.18
1.16
1 Mar 2021
0.76
0.84
1 Feb 2021
0.77
1.13
1 Jan 2021
1
1.19
1 Dec 2020
1.33
1.38
1 Nov 2020
1.15
0.88
1 Oct 2020
0.75
0.46
1 Sep 2020
1.14
0.43
1 Aug 2020
1.27
0.45
1 Jul 2020
1.71
0.68
1 Jun 2020
1.29
0.53
1 May 2020
1
0.66
1 Apr 2020
0.71
0.53
Month
Ciprofloxacin (Watch)
Co-amoxiclav (Watch)
1 Feb 2025
18.46
32.66
1 Jan 2025
19.06
33.38
1 Dec 2024
20.07
33.43
1 Nov 2024
20.35
35.38
1 Oct 2024
20.19
34.36
1 Sep 2024
19.42
33.84
1 Aug 2024
19.03
33.08
1 Jul 2024
19.06
33.78
1 Jun 2024
18.53
33.66
1 May 2024
18.67
33.01
1 Apr 2024
17.68
31.64
1 Mar 2024
17.73
31.98
1 Feb 2024
17.51
33.23
1 Jan 2024
18.24
34.91
1 Dec 2023
18.63
36.42
1 Nov 2023
19.32
35.83
1 Oct 2023
18.38
34.05
1 Sep 2023
18.05
32.87
1 Aug 2023
17.14
31.6
1 Jul 2023
18.95
32.28
1 Jun 2023
19.4
32.52
1 May 2023
19.39
32.12
1 Apr 2023
18.14
32.58
1 Mar 2023
17.94
33.27
1 Feb 2023
17.21
33.3
1 Jan 2023
17.96
33.1
1 Dec 2022
17.51
32.15
1 Nov 2022
17.61
32.16
1 Oct 2022
15.98
31.47
1 Sep 2022
15.79
30.12
1 Aug 2022
15.23
29.05
1 Jul 2022
15.81
27.15
1 Jun 2022
16.72
27.76
1 May 2022
17.66
29.13
1 Apr 2022
18
30.84
1 Mar 2022
17.54
30.49
1 Feb 2022
17.06
30.31
1 Jan 2022
17.4
31.57
1 Dec 2021
17.48
31.87
1 Nov 2021
17
30.84
1 Oct 2021
16.02
28.29
1 Sep 2021
15.38
28.36
1 Aug 2021
15.24
29.32
1 Jul 2021
15.24
30.07
1 Jun 2021
15.27
29.2
1 May 2021
15.05
28.08
1 Apr 2021
14.93
28.8
1 Mar 2021
13.99
29.26
1 Feb 2021
14.51
31
1 Jan 2021
13.76
32.19
1 Dec 2020
14.84
33.19
1 Nov 2020
14.16
31.31
1 Oct 2020
14.52
29.27
1 Sep 2020
13.5
26.85
1 Aug 2020
14.59
28.46
1 Jul 2020
15
29.12
1 Jun 2020
15.21
30.81
1 May 2020
13.34
29.67
1 Apr 2020
13.34
29.82
Month
Gentamicin (Access)
Piperacillin with tazobactam (Watch)
1 Feb 2025
12.85
24.18
1 Jan 2025
11.97
23.52
1 Dec 2024
12.28
24.37
1 Nov 2024
12.71
24.95
1 Oct 2024
13.48
24.51
1 Sep 2024
13.83
23.15
1 Aug 2024
13.61
22.76
1 Jul 2024
12.39
23.38
1 Jun 2024
11.81
23.93
1 May 2024
10.99
23.75
1 Apr 2024
10.61
23.39
1 Mar 2024
10.53
23.61
1 Feb 2024
11.79
23.18
1 Jan 2024
12
24.76
1 Dec 2023
12.03
25.47
1 Nov 2023
11.19
26.39
1 Oct 2023
10.78
24.66
1 Sep 2023
9.42
24.38
1 Aug 2023
9.33
23.21
1 Jul 2023
10.21
22.77
1 Jun 2023
11.44
22.75
1 May 2023
10.95
22.36
1 Apr 2023
10.46
23.42
1 Mar 2023
10.28
23.56
1 Feb 2023
10.09
23.78
1 Jan 2023
10.52
23.7
1 Dec 2022
10.49
22.06
1 Nov 2022
10.83
21.3
1 Oct 2022
10
20.03
1 Sep 2022
9.51
19.83
1 Aug 2022
9.09
19.69
1 Jul 2022
8.31
18.45
1 Jun 2022
8.88
19.14
1 May 2022
9.11
19.96
1 Apr 2022
10.51
20.8
1 Mar 2022
10.26
19.18
1 Feb 2022
10.32
18.54
1 Jan 2022
10.49
19.12
1 Dec 2021
10.46
19.83
1 Nov 2021
10.54
19.59
1 Oct 2021
9.59
17.85
1 Sep 2021
9.04
17.86
1 Aug 2021
8.38
17.54
1 Jul 2021
8.2
19.24
1 Jun 2021
8.25
18.66
1 May 2021
8.62
17.94
1 Apr 2021
9.34
18.01
1 Mar 2021
9.14
17.43
1 Feb 2021
9.24
18.18
1 Jan 2021
8.97
18.27
1 Dec 2020
9.72
19.08
1 Nov 2020
8.77
18.18
1 Oct 2020
7.89
16.12
1 Sep 2020
6.46
14.58
1 Aug 2020
7.14
14.88
1 Jul 2020
7.34
16.51
1 Jun 2020
7.85
17.74
1 May 2020
7.63
16.06
1 Apr 2020
8.84
15.01
Month
Third-generation cephalosporins (Watch)
1 Feb 2025
18.96
1 Jan 2025
19.22
1 Dec 2024
20.6
1 Nov 2024
21.38
1 Oct 2024
22.36
1 Sep 2024
21.56
1 Aug 2024
20.6
1 Jul 2024
19.4
1 Jun 2024
18.99
1 May 2024
18.59
1 Apr 2024
17.42
1 Mar 2024
16.84
1 Feb 2024
17.42
1 Jan 2024
18.5
1 Dec 2023
19.41
1 Nov 2023
20.13
1 Oct 2023
19.12
1 Sep 2023
18.9
1 Aug 2023
17.31
1 Jul 2023
18.8
1 Jun 2023
19.03
1 May 2023
19.15
1 Apr 2023
19.02
1 Mar 2023
18.75
1 Feb 2023
19.12
1 Jan 2023
19.48
1 Dec 2022
19.65
1 Nov 2022
19.18
1 Oct 2022
17.98
1 Sep 2022
16.78
1 Aug 2022
16.59
1 Jul 2022
15.78
1 Jun 2022
16.66
1 May 2022
16.7
1 Apr 2022
17.66
1 Mar 2022
17.42
1 Feb 2022
16.85
1 Jan 2022
17.9
1 Dec 2021
17.76
1 Nov 2021
18.11
1 Oct 2021
15.81
1 Sep 2021
15.52
1 Aug 2021
15.39
1 Jul 2021
15.87
1 Jun 2021
15.87
1 May 2021
15.66
1 Apr 2021
16.01
1 Mar 2021
15.17
1 Feb 2021
15.66
1 Jan 2021
15.59
1 Dec 2020
16.4
1 Nov 2020
15.39
1 Oct 2020
14.39
1 Sep 2020
13.78
1 Aug 2020
14.51
1 Jul 2020
15.6
1 Jun 2020
15.74
1 May 2020
14.67
1 Apr 2020
15.18
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Number tested
1 Feb 2025
502.33
1 Jan 2025
530.33
1 Dec 2024
543.67
1 Nov 2024
555.33
1 Oct 2024
576.67
1 Sep 2024
589
1 Aug 2024
555.67
1 Jul 2024
520.67
1 Jun 2024
484.67
1 May 2024
500
1 Apr 2024
483
1 Mar 2024
480.33
1 Feb 2024
473.67
1 Jan 2024
506
1 Dec 2023
544.33
1 Nov 2023
556
1 Oct 2023
557.33
1 Sep 2023
533.33
1 Aug 2023
521.33
1 Jul 2023
495
1 Jun 2023
475.33
1 May 2023
443.33
1 Apr 2023
428
1 Mar 2023
430.33
1 Feb 2023
452
1 Jan 2023
478.33
1 Dec 2022
485
1 Nov 2022
510.67
1 Oct 2022
499
1 Sep 2022
486
1 Aug 2022
436.33
1 Jul 2022
421
1 Jun 2022
407.33
1 May 2022
413.67
1 Apr 2022
404
1 Mar 2022
406.33
1 Feb 2022
405.33
1 Jan 2022
448.33
1 Dec 2021
481
1 Nov 2021
495.67
1 Oct 2021
461.33
1 Sep 2021
438.67
1 Aug 2021
413
1 Jul 2021
407.33
1 Jun 2021
381.33
1 May 2021
392
1 Apr 2021
395
1 Mar 2021
440.33
1 Feb 2021
431
1 Jan 2021
433.33
1 Dec 2020
401
1 Nov 2020
405
1 Oct 2020
399.67
1 Sep 2020
381
1 Aug 2020
366.67
1 Jul 2020
350.33
1 Jun 2020
361
1 May 2020
367
1 Apr 2020
373.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% tested
1 Feb 2025
66.14
1 Jan 2025
67.09
1 Dec 2024
67.37
1 Nov 2024
68.52
1 Oct 2024
68.98
1 Sep 2024
71.05
1 Aug 2024
69.81
1 Jul 2024
69.71
1 Jun 2024
67.69
1 May 2024
69.44
1 Apr 2024
69.3
1 Mar 2024
69.46
1 Feb 2024
68.55
1 Jan 2024
69.99
1 Dec 2023
71.2
1 Nov 2023
70.74
1 Oct 2023
69.28
1 Sep 2023
68.86
1 Aug 2023
69.47
1 Jul 2023
69.52
1 Jun 2023
69.55
1 May 2023
68.58
1 Apr 2023
68.48
1 Mar 2023
68.47
1 Feb 2023
69.54
1 Jan 2023
69.99
1 Dec 2022
69.78
1 Nov 2022
70.93
1 Oct 2022
69.5
1 Sep 2022
69.23
1 Aug 2022
68.66
1 Jul 2022
70.88
1 Jun 2022
70.78
1 May 2022
70
1 Apr 2022
70.88
1 Mar 2022
70.98
1 Feb 2022
70.8
1 Jan 2022
70
1 Dec 2021
70.74
1 Nov 2021
71.22
1 Oct 2021
69.74
1 Sep 2021
69.09
1 Aug 2021
68.15
1 Jul 2021
68.87
1 Jun 2021
68.65
1 May 2021
70
1 Apr 2021
71.17
1 Mar 2021
72.49
1 Feb 2021
71.36
1 Jan 2021
72.17
1 Dec 2020
70.6
1 Nov 2020
70.56
1 Oct 2020
68.56
1 Sep 2020
68.4
1 Aug 2020
68.8
1 Jul 2020
68.63
1 Jun 2020
70.23
1 May 2020
70.85
1 Apr 2020
72.01
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% resistant
1 Feb 2025
3.12
1 Jan 2025
2.89
1 Dec 2024
3.13
1 Nov 2024
2.88
1 Oct 2024
2.72
1 Sep 2024
2.6
1 Aug 2024
2.64
1 Jul 2024
2.94
1 Jun 2024
2.89
1 May 2024
2.53
1 Apr 2024
2.55
1 Mar 2024
2.15
1 Feb 2024
2.53
1 Jan 2024
1.71
1 Dec 2023
1.9
1 Nov 2023
1.8
1 Oct 2023
1.97
1 Sep 2023
1.88
1 Aug 2023
2.17
1 Jul 2023
2.22
1 Jun 2023
2.59
1 May 2023
2.48
1 Apr 2023
2.26
1 Mar 2023
2.25
1 Feb 2023
1.77
1 Jan 2023
2.37
1 Dec 2022
2.61
1 Nov 2022
3.2
1 Oct 2022
3.07
1 Sep 2022
2.95
1 Aug 2022
2.14
1 Jul 2022
1.66
1 Jun 2022
1.96
1 May 2022
2.42
1 Apr 2022
3.3
1 Mar 2022
3.36
1 Feb 2022
2.96
1 Jan 2022
2.9
1 Dec 2021
2.43
1 Nov 2021
2.62
1 Oct 2021
2.17
1 Sep 2021
2.13
1 Aug 2021
1.69
1 Jul 2021
1.55
1 Jun 2021
1.22
1 May 2021
1.53
1 Apr 2021
1.18
1 Mar 2021
0.76
1 Feb 2021
0.77
1 Jan 2021
1
1 Dec 2020
1.33
1 Nov 2020
1.15
1 Oct 2020
0.75
1 Sep 2020
1.14
1 Aug 2020
1.27
1 Jul 2020
1.71
1 Jun 2020
1.29
1 May 2020
1
1 Apr 2020
0.71
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Number tested
1 Feb 2025
733.67
1 Jan 2025
767.33
1 Dec 2024
781.33
1 Nov 2024
786.67
1 Oct 2024
810
1 Sep 2024
802.67
1 Aug 2024
770
1 Jul 2024
725
1 Jun 2024
695.67
1 May 2024
699.33
1 Apr 2024
673.33
1 Mar 2024
667.33
1 Feb 2024
668
1 Jan 2024
703
1 Dec 2023
743.33
1 Nov 2023
760
1 Oct 2023
772.33
1 Sep 2023
743.33
1 Aug 2023
720.33
1 Jul 2023
685.33
1 Jun 2023
660.33
1 May 2023
626.67
1 Apr 2023
611
1 Mar 2023
614.33
1 Feb 2023
637.67
1 Jan 2023
669
1 Dec 2022
681.67
1 Nov 2022
704.33
1 Oct 2022
700.33
1 Sep 2022
681.33
1 Aug 2022
617.67
1 Jul 2022
579
1 Jun 2022
563.67
1 May 2022
577
1 Apr 2022
560.67
1 Mar 2022
559.33
1 Feb 2022
557.67
1 Jan 2022
620.67
1 Dec 2021
661
1 Nov 2021
677
1 Oct 2021
640.67
1 Sep 2021
612.67
1 Aug 2021
585.67
1 Jul 2021
576
1 Jun 2021
544.33
1 May 2021
548.67
1 Apr 2021
544
1 Mar 2021
595.33
1 Feb 2021
591.33
1 Jan 2021
587
1 Dec 2020
556.67
1 Nov 2020
565
1 Oct 2020
574.33
1 Sep 2020
547.33
1 Aug 2020
517.33
1 Jul 2020
493.33
1 Jun 2020
499.33
1 May 2020
505.67
1 Apr 2020
507.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% tested
1 Feb 2025
96.57
1 Jan 2025
97.09
1 Dec 2024
96.9
1 Nov 2024
97.04
1 Oct 2024
97.01
1 Sep 2024
96.74
1 Aug 2024
96.86
1 Jul 2024
97.18
1 Jun 2024
97.2
1 May 2024
97.08
1 Apr 2024
96.56
1 Mar 2024
96.53
1 Feb 2024
96.81
1 Jan 2024
97.23
1 Dec 2023
97.25
1 Nov 2023
96.69
1 Oct 2023
96.02
1 Sep 2023
95.99
1 Aug 2023
96
1 Jul 2023
96.21
1 Jun 2023
96.63
1 May 2023
96.9
1 Apr 2023
97.76
1 Mar 2023
97.77
1 Feb 2023
98
1 Jan 2023
97.95
1 Dec 2022
97.99
1 Nov 2022
97.91
1 Oct 2022
97.49
1 Sep 2022
97.01
1 Aug 2022
97.17
1 Jul 2022
97.47
1 Jun 2022
97.91
1 May 2022
97.8
1 Apr 2022
98.25
1 Mar 2022
97.73
1 Feb 2022
97.38
1 Jan 2022
96.88
1 Dec 2021
97.21
1 Nov 2021
97.41
1 Oct 2021
96.82
1 Sep 2021
96.53
1 Aug 2021
96.53
1 Jul 2021
97.46
1 Jun 2021
98.02
1 May 2021
97.86
1 Apr 2021
98.02
1 Mar 2021
98.02
1 Feb 2021
97.85
1 Jan 2021
97.83
1 Dec 2020
97.89
1 Nov 2020
98.43
1 Oct 2020
98.63
1 Sep 2020
98.2
1 Aug 2020
97.18
1 Jul 2020
96.67
1 Jun 2020
97.08
1 May 2020
97.49
1 Apr 2020
97.88
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% resistant
1 Feb 2025
1.32
1 Jan 2025
1.26
1 Dec 2024
1.66
1 Nov 2024
1.91
1 Oct 2024
1.85
1 Sep 2024
1.7
1 Aug 2024
1.47
1 Jul 2024
1.7
1 Jun 2024
1.39
1 May 2024
1.38
1 Apr 2024
1.49
1 Mar 2024
1.7
1 Feb 2024
1.7
1 Jan 2024
1.38
1 Dec 2023
1.48
1 Nov 2023
1.58
1 Oct 2023
1.77
1 Sep 2023
1.66
1 Aug 2023
1.48
1 Jul 2023
1.22
1 Jun 2023
1.36
1 May 2023
1.49
1 Apr 2023
1.64
1 Mar 2023
1.68
1 Feb 2023
1.67
1 Jan 2023
1.59
1 Dec 2022
1.52
1 Nov 2022
1.89
1 Oct 2022
1.76
1 Sep 2022
1.81
1 Aug 2022
1.62
1 Jul 2022
1.73
1 Jun 2022
1.66
1 May 2022
1.27
1 Apr 2022
1.01
1 Mar 2022
1.01
1 Feb 2022
1.14
1 Jan 2022
1.72
1 Dec 2021
1.66
1 Nov 2021
1.48
1 Oct 2021
0.99
1 Sep 2021
0.76
1 Aug 2021
0.74
1 Jul 2021
0.75
1 Jun 2021
0.8
1 May 2021
0.97
1 Apr 2021
1.16
1 Mar 2021
0.84
1 Feb 2021
1.13
1 Jan 2021
1.19
1 Dec 2020
1.38
1 Nov 2020
0.88
1 Oct 2020
0.46
1 Sep 2020
0.43
1 Aug 2020
0.45
1 Jul 2020
0.68
1 Jun 2020
0.53
1 May 2020
0.66
1 Apr 2020
0.53
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Number tested
1 Feb 2025
679
1 Jan 2025
704.67
1 Dec 2024
722.33
1 Nov 2024
725.67
1 Oct 2024
757.67
1 Sep 2024
753.33
1 Aug 2024
725.33
1 Jul 2024
678.67
1 Jun 2024
653
1 May 2024
657
1 Apr 2024
641
1 Mar 2024
633.67
1 Feb 2024
634
1 Jan 2024
661.67
1 Dec 2023
705
1 Nov 2023
730
1 Oct 2023
743.67
1 Sep 2023
714.67
1 Aug 2023
688.33
1 Jul 2023
654.33
1 Jun 2023
632.33
1 May 2023
600
1 Apr 2023
584.33
1 Mar 2023
585.33
1 Feb 2023
606.33
1 Jan 2023
638.33
1 Dec 2022
651
1 Nov 2022
677.67
1 Oct 2022
673.67
1 Sep 2022
663
1 Aug 2022
599.67
1 Jul 2022
569.33
1 Jun 2022
550.33
1 May 2022
564.33
1 Apr 2022
546.33
1 Mar 2022
547.33
1 Feb 2022
545
1 Jan 2022
601.67
1 Dec 2021
639
1 Nov 2021
657
1 Oct 2021
628.33
1 Sep 2021
604.67
1 Aug 2021
575.33
1 Jul 2021
562
1 Jun 2021
528.33
1 May 2021
538.33
1 Apr 2021
535.67
1 Mar 2021
586
1 Feb 2021
579
1 Jan 2021
574.33
1 Dec 2020
543.67
1 Nov 2020
553.33
1 Oct 2020
560.33
1 Sep 2020
531
1 Aug 2020
500.33
1 Jul 2020
477.67
1 Jun 2020
486.67
1 May 2020
492.33
1 Apr 2020
494.67
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% tested
1 Feb 2025
89.46
1 Jan 2025
89.11
1 Dec 2024
89.58
1 Nov 2024
89.51
1 Oct 2024
90.66
1 Sep 2024
90.83
1 Aug 2024
91.19
1 Jul 2024
90.88
1 Jun 2024
91.33
1 May 2024
91.25
1 Apr 2024
91.97
1 Mar 2024
91.61
1 Feb 2024
91.88
1 Jan 2024
91.42
1 Dec 2023
92.28
1 Nov 2023
92.88
1 Oct 2023
92.41
1 Sep 2023
92.25
1 Aug 2023
91.73
1 Jul 2023
91.85
1 Jun 2023
92.53
1 May 2023
92.88
1 Apr 2023
93.44
1 Mar 2023
93.15
1 Feb 2023
93.23
1 Jan 2023
93.41
1 Dec 2022
93.67
1 Nov 2022
94.16
1 Oct 2022
93.73
1 Sep 2022
94.44
1 Aug 2022
94.33
1 Jul 2022
95.79
1 Jun 2022
95.65
1 May 2022
95.59
1 Apr 2022
95.79
1 Mar 2022
95.63
1 Feb 2022
95.28
1 Jan 2022
93.91
1 Dec 2021
93.97
1 Nov 2021
94.53
1 Oct 2021
95.01
1 Sep 2021
95.27
1 Aug 2021
94.88
1 Jul 2021
95.09
1 Jun 2021
95.14
1 May 2021
96.07
1 Apr 2021
96.4
1 Mar 2021
96.54
1 Feb 2021
95.86
1 Jan 2021
95.67
1 Dec 2020
95.6
1 Nov 2020
96.34
1 Oct 2020
96.22
1 Sep 2020
95.33
1 Aug 2020
93.98
1 Jul 2020
93.53
1 Jun 2020
94.55
1 May 2020
94.98
1 Apr 2020
95.37
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% resistant
1 Feb 2025
18.46
1 Jan 2025
19.06
1 Dec 2024
20.07
1 Nov 2024
20.35
1 Oct 2024
20.19
1 Sep 2024
19.42
1 Aug 2024
19.03
1 Jul 2024
19.06
1 Jun 2024
18.53
1 May 2024
18.67
1 Apr 2024
17.68
1 Mar 2024
17.73
1 Feb 2024
17.51
1 Jan 2024
18.24
1 Dec 2023
18.63
1 Nov 2023
19.32
1 Oct 2023
18.38
1 Sep 2023
18.05
1 Aug 2023
17.14
1 Jul 2023
18.95
1 Jun 2023
19.4
1 May 2023
19.39
1 Apr 2023
18.14
1 Mar 2023
17.94
1 Feb 2023
17.21
1 Jan 2023
17.96
1 Dec 2022
17.51
1 Nov 2022
17.61
1 Oct 2022
15.98
1 Sep 2022
15.79
1 Aug 2022
15.23
1 Jul 2022
15.81
1 Jun 2022
16.72
1 May 2022
17.66
1 Apr 2022
18
1 Mar 2022
17.54
1 Feb 2022
17.06
1 Jan 2022
17.4
1 Dec 2021
17.48
1 Nov 2021
17
1 Oct 2021
16.02
1 Sep 2021
15.38
1 Aug 2021
15.24
1 Jul 2021
15.24
1 Jun 2021
15.27
1 May 2021
15.05
1 Apr 2021
14.93
1 Mar 2021
13.99
1 Feb 2021
14.51
1 Jan 2021
13.76
1 Dec 2020
14.84
1 Nov 2020
14.16
1 Oct 2020
14.52
1 Sep 2020
13.5
1 Aug 2020
14.59
1 Jul 2020
15
1 Jun 2020
15.21
1 May 2020
13.34
1 Apr 2020
13.34
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Number tested
1 Feb 2025
679.67
1 Jan 2025
703
1 Dec 2024
720
1 Nov 2024
718
1 Oct 2024
744
1 Sep 2024
742.67
1 Aug 2024
715.33
1 Jul 2024
674
1 Jun 2024
648.67
1 May 2024
650.33
1 Apr 2024
629
1 Mar 2024
617
1 Feb 2024
620
1 Jan 2024
654
1 Dec 2023
691
1 Nov 2023
716.33
1 Oct 2023
726.33
1 Sep 2023
702.67
1 Aug 2023
675
1 Jul 2023
645.33
1 Jun 2023
617
1 May 2023
585.33
1 Apr 2023
560.67
1 Mar 2023
569
1 Feb 2023
591.67
1 Jan 2023
625.33
1 Dec 2022
638.67
1 Nov 2022
653
1 Oct 2022
655.67
1 Sep 2022
639.67
1 Aug 2022
591
1 Jul 2022
558.67
1 Jun 2022
544
1 May 2022
552.67
1 Apr 2022
535
1 Mar 2022
534.67
1 Feb 2022
536.67
1 Jan 2022
598.67
1 Dec 2021
638
1 Nov 2021
649.67
1 Oct 2021
617.33
1 Sep 2021
594.67
1 Aug 2021
573
1 Jul 2021
557.67
1 Jun 2021
519.33
1 May 2021
524.67
1 Apr 2021
522
1 Mar 2021
573
1 Feb 2021
567.67
1 Jan 2021
565.33
1 Dec 2020
535.33
1 Nov 2020
544
1 Oct 2020
550
1 Sep 2020
527.67
1 Aug 2020
501.33
1 Jul 2020
483
1 Jun 2020
489
1 May 2020
494.33
1 Apr 2020
487.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% tested
1 Feb 2025
89.46
1 Jan 2025
88.99
1 Dec 2024
89.33
1 Nov 2024
88.64
1 Oct 2024
89.1
1 Sep 2024
89.51
1 Aug 2024
89.94
1 Jul 2024
90.35
1 Jun 2024
90.63
1 May 2024
90.28
1 Apr 2024
90.24
1 Mar 2024
89.29
1 Feb 2024
89.86
1 Jan 2024
90.46
1 Dec 2023
90.45
1 Nov 2023
91.09
1 Oct 2023
90.3
1 Sep 2023
90.7
1 Aug 2023
90
1 Jul 2023
90.59
1 Jun 2023
90.34
1 May 2023
90.56
1 Apr 2023
89.6
1 Mar 2023
90.61
1 Feb 2023
90.92
1 Jan 2023
91.51
1 Dec 2022
91.8
1 Nov 2022
90.82
1 Oct 2022
91.23
1 Sep 2022
91.03
1 Aug 2022
93.07
1 Jul 2022
93.94
1 Jun 2022
94.61
1 May 2022
93.56
1 Apr 2022
93.86
1 Mar 2022
93.36
1 Feb 2022
93.71
1 Jan 2022
93.44
1 Dec 2021
93.82
1 Nov 2021
93.38
1 Oct 2021
93.34
1 Sep 2021
93.69
1 Aug 2021
94.55
1 Jul 2021
94.25
1 Jun 2021
93.51
1 May 2021
93.57
1 Apr 2021
94.05
1 Mar 2021
94.4
1 Feb 2021
93.87
1 Jan 2021
94.17
1 Dec 2020
94.19
1 Nov 2020
94.77
1 Oct 2020
94.5
1 Sep 2020
94.61
1 Aug 2020
94.17
1 Jul 2020
94.71
1 Jun 2020
95.14
1 May 2020
95.37
1 Apr 2020
94.02
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% resistant
1 Feb 2025
32.66
1 Jan 2025
33.38
1 Dec 2024
33.43
1 Nov 2024
35.38
1 Oct 2024
34.36
1 Sep 2024
33.84
1 Aug 2024
33.08
1 Jul 2024
33.78
1 Jun 2024
33.66
1 May 2024
33.01
1 Apr 2024
31.64
1 Mar 2024
31.98
1 Feb 2024
33.23
1 Jan 2024
34.91
1 Dec 2023
36.42
1 Nov 2023
35.83
1 Oct 2023
34.05
1 Sep 2023
32.87
1 Aug 2023
31.6
1 Jul 2023
32.28
1 Jun 2023
32.52
1 May 2023
32.12
1 Apr 2023
32.58
1 Mar 2023
33.27
1 Feb 2023
33.3
1 Jan 2023
33.1
1 Dec 2022
32.15
1 Nov 2022
32.16
1 Oct 2022
31.47
1 Sep 2022
30.12
1 Aug 2022
29.05
1 Jul 2022
27.15
1 Jun 2022
27.76
1 May 2022
29.13
1 Apr 2022
30.84
1 Mar 2022
30.49
1 Feb 2022
30.31
1 Jan 2022
31.57
1 Dec 2021
31.87
1 Nov 2021
30.84
1 Oct 2021
28.29
1 Sep 2021
28.36
1 Aug 2021
29.32
1 Jul 2021
30.07
1 Jun 2021
29.2
1 May 2021
28.08
1 Apr 2021
28.8
1 Mar 2021
29.26
1 Feb 2021
31
1 Jan 2021
32.19
1 Dec 2020
33.19
1 Nov 2020
31.31
1 Oct 2020
29.27
1 Sep 2020
26.85
1 Aug 2020
28.46
1 Jul 2020
29.12
1 Jun 2020
30.81
1 May 2020
29.67
1 Apr 2020
29.82
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Number tested
1 Feb 2025
692.67
1 Jan 2025
718.33
1 Dec 2024
733
1 Nov 2024
742
1 Oct 2024
771.33
1 Sep 2024
766.33
1 Aug 2024
735
1 Jul 2024
691.33
1 Jun 2024
666
1 May 2024
664.33
1 Apr 2024
634.33
1 Mar 2024
630
1 Feb 2024
639
1 Jan 2024
675
1 Dec 2023
714.67
1 Nov 2023
730
1 Oct 2023
751.33
1 Sep 2023
718.67
1 Aug 2023
696.67
1 Jul 2023
663
1 Jun 2023
641
1 May 2023
609
1 Apr 2023
586.33
1 Mar 2023
590
1 Feb 2023
611
1 Jan 2023
646.33
1 Dec 2022
657.67
1 Nov 2022
683
1 Oct 2022
676.33
1 Sep 2022
665.67
1 Aug 2022
605
1 Jul 2022
573.33
1 Jun 2022
555.67
1 May 2022
570.67
1 Apr 2022
555
1 Mar 2022
555.33
1 Feb 2022
555.33
1 Jan 2022
616.67
1 Dec 2021
656.33
1 Nov 2021
673.67
1 Oct 2021
639.33
1 Sep 2021
612
1 Aug 2021
580.67
1 Jul 2021
569
1 Jun 2021
537.33
1 May 2021
545
1 Apr 2021
542.67
1 Mar 2021
594.33
1 Feb 2021
588.33
1 Jan 2021
583.33
1 Dec 2020
552.33
1 Nov 2020
559
1 Oct 2020
566
1 Sep 2020
541.67
1 Aug 2020
518.33
1 Jul 2020
499.67
1 Jun 2020
505
1 May 2020
502.33
1 Apr 2020
501.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% tested
1 Feb 2025
91.17
1 Jan 2025
90.89
1 Dec 2024
90.94
1 Nov 2024
91.6
1 Oct 2024
92.34
1 Sep 2024
92.4
1 Aug 2024
92.45
1 Jul 2024
92.63
1 Jun 2024
93.15
1 May 2024
92.22
1 Apr 2024
90.96
1 Mar 2024
91.17
1 Feb 2024
92.61
1 Jan 2024
93.36
1 Dec 2023
93.46
1 Nov 2023
92.88
1 Oct 2023
93.41
1 Sep 2023
92.76
1 Aug 2023
92.8
1 Jul 2023
93.12
1 Jun 2023
93.85
1 May 2023
94.27
1 Apr 2023
93.76
1 Mar 2023
93.95
1 Feb 2023
94
1 Jan 2023
94.58
1 Dec 2022
94.53
1 Nov 2022
94.99
1 Oct 2022
94.15
1 Sep 2022
94.73
1 Aug 2022
95.28
1 Jul 2022
96.46
1 Jun 2022
96.52
1 May 2022
96.61
1 Apr 2022
97.37
1 Mar 2022
97.03
1 Feb 2022
97.03
1 Jan 2022
96.25
1 Dec 2021
96.47
1 Nov 2021
96.83
1 Oct 2021
96.67
1 Sep 2021
96.53
1 Aug 2021
95.71
1 Jul 2021
96.28
1 Jun 2021
96.76
1 May 2021
97.32
1 Apr 2021
97.66
1 Mar 2021
97.86
1 Feb 2021
97.35
1 Jan 2021
97.17
1 Dec 2020
97.18
1 Nov 2020
97.39
1 Oct 2020
97.25
1 Sep 2020
97.13
1 Aug 2020
97.37
1 Jul 2020
97.84
1 Jun 2020
98.25
1 May 2020
96.91
1 Apr 2020
96.72
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% resistant
1 Feb 2025
12.85
1 Jan 2025
11.97
1 Dec 2024
12.28
1 Nov 2024
12.71
1 Oct 2024
13.48
1 Sep 2024
13.83
1 Aug 2024
13.61
1 Jul 2024
12.39
1 Jun 2024
11.81
1 May 2024
10.99
1 Apr 2024
10.61
1 Mar 2024
10.53
1 Feb 2024
11.79
1 Jan 2024
12
1 Dec 2023
12.03
1 Nov 2023
11.19
1 Oct 2023
10.78
1 Sep 2023
9.42
1 Aug 2023
9.33
1 Jul 2023
10.21
1 Jun 2023
11.44
1 May 2023
10.95
1 Apr 2023
10.46
1 Mar 2023
10.28
1 Feb 2023
10.09
1 Jan 2023
10.52
1 Dec 2022
10.49
1 Nov 2022
10.83
1 Oct 2022
10
1 Sep 2022
9.51
1 Aug 2022
9.09
1 Jul 2022
8.31
1 Jun 2022
8.88
1 May 2022
9.11
1 Apr 2022
10.51
1 Mar 2022
10.26
1 Feb 2022
10.32
1 Jan 2022
10.49
1 Dec 2021
10.46
1 Nov 2021
10.54
1 Oct 2021
9.59
1 Sep 2021
9.04
1 Aug 2021
8.38
1 Jul 2021
8.2
1 Jun 2021
8.25
1 May 2021
8.62
1 Apr 2021
9.34
1 Mar 2021
9.14
1 Feb 2021
9.24
1 Jan 2021
8.97
1 Dec 2020
9.72
1 Nov 2020
8.77
1 Oct 2020
7.89
1 Sep 2020
6.46
1 Aug 2020
7.14
1 Jul 2020
7.34
1 Jun 2020
7.85
1 May 2020
7.63
1 Apr 2020
8.84
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Number tested
1 Feb 2025
693.33
1 Jan 2025
720
1 Dec 2024
733
1 Nov 2024
721.33
1 Oct 2024
735.67
1 Sep 2024
724.33
1 Aug 2024
701.67
1 Jul 2024
661.67
1 Jun 2024
636.67
1 May 2024
638.67
1 Apr 2024
612.67
1 Mar 2024
604.33
1 Feb 2024
601
1 Jan 2024
636.67
1 Dec 2023
680.67
1 Nov 2023
702.33
1 Oct 2023
709.67
1 Sep 2023
682.33
1 Aug 2023
662
1 Jul 2023
635.33
1 Jun 2023
608
1 May 2023
574
1 Apr 2023
558
1 Mar 2023
563
1 Feb 2023
587.33
1 Jan 2023
616
1 Dec 2022
627
1 Nov 2022
648
1 Oct 2022
644
1 Sep 2022
630.33
1 Aug 2022
577.33
1 Jul 2022
545.67
1 Jun 2022
527.67
1 May 2022
532.67
1 Apr 2022
514.33
1 Mar 2022
519.67
1 Feb 2022
521.33
1 Jan 2022
587.67
1 Dec 2021
622
1 Nov 2021
641.33
1 Oct 2021
603.33
1 Sep 2021
578.67
1 Aug 2021
553
1 Jul 2021
544
1 Jun 2021
516.33
1 May 2021
518.33
1 Apr 2021
514.67
1 Mar 2021
562.33
1 Feb 2021
561
1 Jan 2021
554.67
1 Dec 2020
524
1 Nov 2020
530
1 Oct 2020
539.67
1 Sep 2020
516.67
1 Aug 2020
486
1 Jul 2020
464.33
1 Jun 2020
469.67
1 May 2020
477.33
1 Apr 2020
475.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% tested
1 Feb 2025
91.3
1 Jan 2025
91.14
1 Dec 2024
90.94
1 Nov 2024
89.01
1 Oct 2024
88.02
1 Sep 2024
87.33
1 Aug 2024
88.18
1 Jul 2024
88.61
1 Jun 2024
88.95
1 May 2024
88.61
1 Apr 2024
87.8
1 Mar 2024
87.41
1 Feb 2024
87.1
1 Jan 2024
87.97
1 Dec 2023
89.01
1 Nov 2023
89.31
1 Oct 2023
88.18
1 Sep 2023
88.11
1 Aug 2023
88.27
1 Jul 2023
89.19
1 Jun 2023
89.02
1 May 2023
88.85
1 Apr 2023
89.28
1 Mar 2023
89.65
1 Feb 2023
90.31
1 Jan 2023
90.19
1 Dec 2022
90.22
1 Nov 2022
90.13
1 Oct 2022
89.69
1 Sep 2022
89.74
1 Aug 2022
90.87
1 Jul 2022
91.75
1 Jun 2022
91.65
1 May 2022
90.17
1 Apr 2022
90.18
1 Mar 2022
90.73
1 Feb 2022
91.08
1 Jan 2022
91.72
1 Dec 2021
91.47
1 Nov 2021
92.23
1 Oct 2021
91.23
1 Sep 2021
91.17
1 Aug 2021
91.25
1 Jul 2021
92.05
1 Jun 2021
92.97
1 May 2021
92.5
1 Apr 2021
92.61
1 Mar 2021
92.59
1 Feb 2021
92.88
1 Jan 2021
92.33
1 Dec 2020
92.25
1 Nov 2020
92.33
1 Oct 2020
92.61
1 Sep 2020
92.64
1 Aug 2020
91.35
1 Jul 2020
90.98
1 Jun 2020
91.25
1 May 2020
92.08
1 Apr 2020
91.7
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% resistant
1 Feb 2025
24.18
1 Jan 2025
23.52
1 Dec 2024
24.37
1 Nov 2024
24.95
1 Oct 2024
24.51
1 Sep 2024
23.15
1 Aug 2024
22.76
1 Jul 2024
23.38
1 Jun 2024
23.93
1 May 2024
23.75
1 Apr 2024
23.39
1 Mar 2024
23.61
1 Feb 2024
23.18
1 Jan 2024
24.76
1 Dec 2023
25.47
1 Nov 2023
26.39
1 Oct 2023
24.66
1 Sep 2023
24.38
1 Aug 2023
23.21
1 Jul 2023
22.77
1 Jun 2023
22.75
1 May 2023
22.36
1 Apr 2023
23.42
1 Mar 2023
23.56
1 Feb 2023
23.78
1 Jan 2023
23.7
1 Dec 2022
22.06
1 Nov 2022
21.3
1 Oct 2022
20.03
1 Sep 2022
19.83
1 Aug 2022
19.69
1 Jul 2022
18.45
1 Jun 2022
19.14
1 May 2022
19.96
1 Apr 2022
20.8
1 Mar 2022
19.18
1 Feb 2022
18.54
1 Jan 2022
19.12
1 Dec 2021
19.83
1 Nov 2021
19.59
1 Oct 2021
17.85
1 Sep 2021
17.86
1 Aug 2021
17.54
1 Jul 2021
19.24
1 Jun 2021
18.66
1 May 2021
17.94
1 Apr 2021
18.01
1 Mar 2021
17.43
1 Feb 2021
18.18
1 Jan 2021
18.27
1 Dec 2020
19.08
1 Nov 2020
18.18
1 Oct 2020
16.12
1 Sep 2020
14.58
1 Aug 2020
14.88
1 Jul 2020
16.51
1 Jun 2020
17.74
1 May 2020
16.06
1 Apr 2020
15.01
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
Number tested
1 Feb 2025
729.67
1 Jan 2025
759.67
1 Dec 2024
775
1 Nov 2024
782.67
1 Oct 2024
811
1 Sep 2024
805.67
1 Aug 2024
771.67
1 Jul 2024
721.67
1 Jun 2024
690
1 May 2024
695.67
1 Apr 2024
675.33
1 Mar 2024
669
1 Feb 2024
667.67
1 Jan 2024
699
1 Dec 2023
740.33
1 Nov 2023
760
1 Oct 2023
774
1 Sep 2023
746
1 Aug 2023
722
1 Jul 2023
688
1 Jun 2023
660.33
1 May 2023
626.67
1 Apr 2023
608
1 Mar 2023
609.67
1 Feb 2023
633
1 Jan 2023
667.33
1 Dec 2022
682
1 Nov 2022
705.67
1 Oct 2022
700.67
1 Sep 2022
681.33
1 Aug 2022
616.67
1 Jul 2022
576.67
1 Jun 2022
562.33
1 May 2022
577
1 Apr 2022
562.33
1 Mar 2022
560.67
1 Feb 2022
558
1 Jan 2022
622
1 Dec 2021
662.67
1 Nov 2021
677.33
1 Oct 2021
641
1 Sep 2021
614.33
1 Aug 2021
589
1 Jul 2021
575.67
1 Jun 2021
542
1 May 2021
547
1 Apr 2021
543.33
1 Mar 2021
595.33
1 Feb 2021
589.67
1 Jan 2021
585.67
1 Dec 2020
555
1 Nov 2020
563
1 Oct 2020
572
1 Sep 2020
544.33
1 Aug 2020
514.67
1 Jul 2020
491.33
1 Jun 2020
495.67
1 May 2020
502
1 Apr 2020
503
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% tested
1 Feb 2025
96.05
1 Jan 2025
96.08
1 Dec 2024
96.15
1 Nov 2024
96.54
1 Oct 2024
97.13
1 Sep 2024
97.1
1 Aug 2024
96.98
1 Jul 2024
96.65
1 Jun 2024
96.5
1 May 2024
96.53
1 Apr 2024
96.84
1 Mar 2024
96.82
1 Feb 2024
96.67
1 Jan 2024
96.68
1 Dec 2023
96.86
1 Nov 2023
96.69
1 Oct 2023
96.27
1 Sep 2023
96.38
1 Aug 2023
96.27
1 Jul 2023
96.63
1 Jun 2023
96.63
1 May 2023
96.9
1 Apr 2023
97.28
1 Mar 2023
96.97
1 Feb 2023
97.38
1 Jan 2023
97.66
1 Dec 2022
98.13
1 Nov 2022
98.05
1 Oct 2022
97.49
1 Sep 2022
97.01
1 Aug 2022
97.01
1 Jul 2022
96.97
1 Jun 2022
97.74
1 May 2022
97.8
1 Apr 2022
98.6
1 Mar 2022
97.9
1 Feb 2022
97.55
1 Jan 2022
97.19
1 Dec 2021
97.35
1 Nov 2021
97.41
1 Oct 2021
96.97
1 Sep 2021
96.85
1 Aug 2021
97.19
1 Jul 2021
97.29
1 Jun 2021
97.66
1 May 2021
97.68
1 Apr 2021
97.84
1 Mar 2021
98.02
1 Feb 2021
97.52
1 Jan 2021
97.5
1 Dec 2020
97.71
1 Nov 2020
98.08
1 Oct 2020
98.28
1 Sep 2020
97.67
1 Aug 2020
96.62
1 Jul 2020
96.27
1 Jun 2020
96.3
1 May 2020
96.91
1 Apr 2020
97.1
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of K. pneumoniae bacteraemia resistant to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 February 2025
Month
% resistant
1 Feb 2025
18.96
1 Jan 2025
19.22
1 Dec 2024
20.6
1 Nov 2024
21.38
1 Oct 2024
22.36
1 Sep 2024
21.56
1 Aug 2024
20.6
1 Jul 2024
19.4
1 Jun 2024
18.99
1 May 2024
18.59
1 Apr 2024
17.42
1 Mar 2024
16.84
1 Feb 2024
17.42
1 Jan 2024
18.5
1 Dec 2023
19.41
1 Nov 2023
20.13
1 Oct 2023
19.12
1 Sep 2023
18.9
1 Aug 2023
17.31
1 Jul 2023
18.8
1 Jun 2023
19.03
1 May 2023
19.15
1 Apr 2023
19.02
1 Mar 2023
18.75
1 Feb 2023
19.12
1 Jan 2023
19.48
1 Dec 2022
19.65
1 Nov 2022
19.18
1 Oct 2022
17.98
1 Sep 2022
16.78
1 Aug 2022
16.59
1 Jul 2022
15.78
1 Jun 2022
16.66
1 May 2022
16.7
1 Apr 2022
17.66
1 Mar 2022
17.42
1 Feb 2022
16.85
1 Jan 2022
17.9
1 Dec 2021
17.76
1 Nov 2021
18.11
1 Oct 2021
15.81
1 Sep 2021
15.52
1 Aug 2021
15.39
1 Jul 2021
15.87
1 Jun 2021
15.87
1 May 2021
15.66
1 Apr 2021
16.01
1 Mar 2021
15.17
1 Feb 2021
15.66
1 Jan 2021
15.59
1 Dec 2020
16.4
1 Nov 2020
15.39
1 Oct 2020
14.39
1 Sep 2020
13.78
1 Aug 2020
14.51
1 Jul 2020
15.6
1 Jun 2020
15.74
1 May 2020
14.67
1 Apr 2020
15.18
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
The ESPAUR report includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation, and awareness activities.